Product image of Marvelon (Desogestrel, Ethinylestradiol) supplied by GNH India

Marvelon

Active Ingredient:
Desogestrel, Ethinylestradiol
Origin:
EU

Marvelon (Desogestrel, Ethinylestradiol)

Desogestrel, the active ingredient in Marvelon, is a combined oral contraceptive presented as 150 µg desogestrel / 30 µg ethinylestradiol oral tablet for oral use. It prevents pregnancy and provides hormonal contraception for women of reproductive age, while the ethinylestradiol component helps regulate the menstrual cycle.

GNH India supplies Marvelon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Organon Belgium B.V.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Marvelon, a combined oral contraceptive, is used within the hormonal contraception pathway to prevent unintended pregnancy.

  • Pregnancy prevention: provides reliable hormonal contraception for women of reproductive age.
  • Menstrual cycle regulation: helps achieve more predictable bleeding patterns and reduces dysmenorrhea.
  • Management of estrogen‑dependent conditions: may be prescribed to treat certain menstrual disorders such as endometriosis‑related pain.

How It Works

  • Marvelon combines desogestrel, a progestogenic agent, with ethinylestradiol, a synthetic estrogen. The estrogen‑progestogen pair suppresses the hypothalamic‑pituitary‑ovarian axis, inhibiting the release of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH), thereby preventing ovulation. In addition, the formulation thickens cervical mucus and induces endometrial changes that reduce the likelihood of fertilisation and implantation.

Side Effects

Common and serious adverse reactions have been reported with combined oral contraceptives such as Marvelon.

Common Side Effects

  • Nausea
  • Breast tenderness
  • Headache
  • Weight gain
  • Mood changes
  • Spotting between periods

Serious or Rare Side Effects

  • Venous thromboembolism (deep‑vein thrombosis, pulmonary embolism)
  • Arterial thrombosis (stroke, myocardial infarction)
  • Severe hypertension
  • Liver dysfunction or cholestasis
  • Allergic reactions (anaphylaxis, severe rash)

Precautions & Warnings

Before prescribing Marvelon, clinicians should consider several safety and handling precautions.

  • Contraindicated in pregnancy: the product must not be used by women who are or may become pregnant.
  • Smoking over age 35: increases risk of cardiovascular events and is a contraindication.
  • History of thromboembolism: avoid use in patients with prior deep‑vein thrombosis or pulmonary embolism.
  • Liver disease: impaired hepatic function may alter hormone metabolism.
  • Hypertension: uncontrolled high blood pressure requires caution or avoidance.
  • Store at ambient temperature: keep below 25 °C, in the original packaging, protected from moisture and light.

Avoid Interactions

Marvelon may interact with several medicines that alter hormone levels or increase the risk of adverse events.

Major Interactions (Avoid)

  • Enzyme‑inducing anticonvulsants (e.g., carbamazepine, phenytoin) markedly reduce contraceptive efficacy.
  • Rifampicin and other strong CYP3A4 inducers can lead to contraceptive failure.
  • St John’s wort: herbal inducer that may lower hormone concentrations.
  • Certain antiretrovirals (e.g., ritonavir) may increase hormone levels and risk of side effects.

Moderate Interactions (Monitor Closely)

  • Antihypertensives: oral contraceptives may diminish blood‑pressure‑lowering effect.
  • SSRIs and other antidepressants: may increase bleeding tendency.
  • Diuretics: can affect electrolyte balance when combined with estrogen.
  • Antifungals (e.g., fluconazole) may raise hormone levels modestly.

Frequently Asked Questions

Marvelon is prescribed as a hormonal contraceptive to prevent unintended pregnancy in women of reproductive age. It may also be used to regulate menstrual cycles and to manage certain estrogen‑dependent menstrual disorders.

The combination of desogestrel (a progestogen) and ethinylestradiol (a synthetic estrogen) suppresses the release of luteinizing hormone and follicle‑stimulating hormone, preventing ovulation. It also thickens cervical mucus and alters the endometrium, creating an environment that is unfavorable for fertilisation and implantation.

The dosing regimen for Marvelon is determined by the prescribing clinician. Typically, the product is supplied as a pack of tablets that are taken once daily at the same time for a defined cycle, but the exact schedule should follow the prescriber’s instructions.

Marvelon must not be used during pregnancy, as it is intended to prevent conception. If pregnancy occurs, the product should be discontinued. Limited data are available for breastfeeding; clinicians usually weigh the benefits against potential risks before recommending use in nursing mothers.

To place an order, submit an enquiry on the Marvelon product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, and will request verification of trade or institutional credentials before providing pricing, availability, shipping details and any necessary import documentation.

Marvelon contains desogestrel, a third‑generation progestogen, which is associated with a lower incidence of androgenic side effects compared with some older formulations. Its efficacy in preventing pregnancy is comparable to other combined oral contraceptives, while the side‑effect profile may differ based on the progestogen component.

Marvelon tablets should be stored at ambient temperature, below 25 °C, in the original blister pack. Protect them from moisture, direct sunlight and excessive heat to maintain product stability throughout the shelf life.

Marvelon is taken orally as a tablet, usually once daily at the same time each day. The tablets are swallowed with water and should be taken with or without food, following the schedule prescribed by the healthcare professional.

The most serious risks include venous and arterial thromboembolic events such as deep‑vein thrombosis, pulmonary embolism, stroke, and myocardial infarction. Additional concerns are severe hypertension, liver disorders, and rare allergic reactions. Patients should seek immediate medical attention if they experience symptoms suggestive of these conditions.

Marvelon is contraindicated in women who are pregnant or breastfeeding, smokers over 35 years of age, and those with a history of thromboembolic disease, uncontrolled hypertension, severe liver disease, or known hypersensitivity to any component of the product.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Desogestrel, Ethinylestradiol

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT